FDA Clearance Tracker · P040001-S002
X STOP INTERSPINOUS PROCESS DECOMPRESSION SYSTEM
Last checked: Nov 20, 2026Latest source record: Aug 8, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Aug 8, 2006
Approved
Time to decision
160 days
Received Mar 1, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040001-S002
- Device name
- X STOP INTERSPINOUS PROCESS DECOMPRESSION SYSTEM
- Applicant
- Medtronic Sofamor Danek, Inc.
- Applicant location
- Memphis, TN
- Received
- Mar 1, 2006
- Decided
- Aug 8, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040001
Device type
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE X STOPPK, A MODIFIED VERSION OF THE X STOP THAT INCLUDES A PEEK SPACER AND ADDITIONAL 16 MM SPACER SIZE. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME X STOPPK AND IS INDICATED FOR TREATMENT OF PATIENTS AGED 50 OR OLDER SUFFERING FROM NEUROGENIC INTERMITTENT CLAUDICATION SECONDARY TO A CONFIRMED DIAGNOSIS OF LUMBAR SPINAL STENOSIS (WITH X-RAY, MRI, AND/OR CT EVIDENCE OF THICKENING LIGAMENTUM FLAVUM, NARROWED LATERAL RECESS AND/OR CENTRAL CONAL NARROWING). THE X STOPPK IS INDICATED FOR THOSE PATIENTS WITH MODERATELY IMPAIRED PHYSICAL FUNCTION WHO EXPERIENCE RELIEF IN FLEXION FROM THEIR SYMPTOMS OF LEG/BUTTOCK/GROIN PAIN, WITH OR WITHOUT BACK PAIN, AND HAVE UNDERGONE A REGIMEN OF AT LEAST 6 MONTHS OF NONOPERATIVE TREATMENT. THE X STOPPK MAY BE IMPLANTED AT ONE OR TWO LUMBAR LEVELS IN PATIENTS IN WHOM OPERATIVE TREATMENT IS INDICATED AT NO MORE THAN TWO LEVELS.
Source documents
Other decisions for Medtronic Sofamor Danek, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251193 · Decided Jun 12, 2025 · 56 days after receipt
Device type: Filler, Bone Void, Calcium Compound (MQV) · Orthopedic Surgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.